ArticleCardiovascular diabetology2024

Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials.

Young Sang Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.